Then you can take action: segment it, quarantine it, or apply new policies. We’re also introducing AI-driven analysis—what we call the “automated analyst.” You can choose a persona, like threat hunter ...

BOSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Sesen today announced the launch of TrialS, a next generation regulatory ...

Flywheel Validated unlocks a critical bottleneck in clinical research by helping pharmaceutical sponsors, reading centers, CROs, and academic medical centers access and analyze their clinical trial ...

DelveInsight delivered comprehensive conference coverage across major respiratory events to support a client developing an ...

Culminating with the 4YFN26 Awards, the Top 20 will compete to be crowned overall winner. The 4YFN Top 20 will take part in the 4YFN Awards semifinals on the first day of 4YFN Barcelona. This on-stage ...

FlutterFlow today announced that Dreamflow Buildathon 2025, a global 50-day app-building challenge launched earlier this month, is already inspiring creators, designers, and entrepreneurs worldwide to ...

Axelar, the Gateway to Onchain Finance, today announces the release of AgentFlux, a new open-source framework for privacy-preserving, on-device agentic AI. Built to run powerful AI agents locally on ...

BENGALURU, India, - As enterprises race to deploy AI applications, they're discovering that their observability infrastructure can't ...

Subtle Medical, a leader in AI technology for faster and higher quality medical imaging, is set to showcase its latest innovations at the 2025 Radiological Society of North America (RSNA) conference.

All Approved Indications Of Five Akeso's Innovative Drugs Included In China's Latest NRDL: Featuring Two First-In-Class Bispecifics With New First-Line Indications And Three Newly Negotiated Drugs.

Detailed price information for Datatrak International Inc (DTRK) from The Globe and Mail including charting and trades.

When Alessandro Barbera was rushed to a California hospital with infant botulism in October, his father had barely heard of ...